Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2015-08-10

Clinical Trial Update: Effect of Testosterone Gel Replacement on Fat Mass in Males With Low Testosterone Levels and Diabetes [Phase 4]

View source ↗

Summary

A Phase 4 trial investigating testosterone gel replacement for fat mass in men with hypogonadism and diabetes has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Testosterone gel (Testosterone)

Snippet

Sponsor: Diabetes Center of the Southwest | Conditions: Hypogonadism, Diabetes | Phase 4 | Status: WITHDRAWN